Status:
UNKNOWN
Enhanced Recovery With Liposomal Bupivacaine in Orthognathic Surgery
Lead Sponsor:
University of Texas at Austin
Conditions:
Pain, Postoperative
Eligibility:
All Genders
15-25 years
Phase:
PHASE4
Brief Summary
The proposed study design is a prospective, clinical trial comparing control group patients (CG; ncg = 30) that will undergo conventional perioperative management without an ERAS protocol and standard...
Detailed Description
The proposed study design is a prospective, clinical trial comparing control group patients (CG; ncg = 30) that will undergo conventional perioperative management without an ERAS protocol and standard...
Eligibility Criteria
Inclusion
- All patients undergoing orthognathic surgery at Dell Children's Medical Center will be intended for inclusion in the study.
Exclusion
- Only those patients with insufficient data in their medical records or contraindications to the administration of liposomal bupivacaine (hepatic disease or allergy to amide local anesthetics) will be excluded from the study.
Key Trial Info
Start Date :
May 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03844451
Start Date
May 17 2019
End Date
November 1 2019
Last Update
February 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dell Children's Medical Center
Austin, Texas, United States, 78723